Teva Pharmaceutical Industries (TEVA) has begun trading its ordinary shares directly on the New York Stock Exchange, marking a significant milestone for the global drugmaker. The move represents a key step in Teva’s broader strategic pivot toward growth, as the company works to reposition
On August 26, 2026, President Trump signed Executive Order 14421, invoking the
AbbVie has announced positive topline results from its Phase 3 LUNA study
London stocks closed lower on Tuesday as Bank of England Governor Andrew
